SC, Here's an interesting stock idea - Cempra (CEMP). I had been following some of these antibiotic stocks loosely (due to CTIX's Brilacidin), and CEMP and TTPH are in that area also.
TTPH blew up last Fall and CEMP went down in sympathy, and then in the big January drop in the stock market, CEMP raised some money, which sent it down even more. But it's recovering ahead of the coming FDA advisory meeting (Nov 4) and then the PDUFA date in late December.
The odds of approval appear high, and their antibiotic works even better than Levaquin (for bacterial pneumonia) and without the serious side effect risk. I listened to the most recent investor presentation (Sept 27) and it really looks interesting. I bought a modest amount, along with several turnaround plays (FLO, SRCL). Real small positions, mostly for fun. FLO and SRCL were on my 'Best Long Term Stocks' list but got hit over the past year due to what appear to be temporary setbacks.
So these are bottom/turnaround plays of basically solid companies. Should be interesting, but instead I should probably be accumulating HDGE like you guys. If Rickards is right though, the Fedsters may be looking to start up the liquidity machine again and engineer a lower dollar, which would presumably keep the bull market in stocks going. But tough to say what craziness awaits after the election, so gold/silver remain the 'go to' investment as we head ever closer to the inevitable.
